Clearance of amyloid-β by circulating lipoprotein receptors

Abhay Sagare, Rashid Deane, Robert D. Bell, Bradley Johnson, Katie Hamm, Ronan Pendu, Andrew Marky, Peter J. Lenting, Zhenhua Wu, Troy Zarcone, Alison Goate, Kevin Mayo, David Perlmutter, Mireia Coma, Zhihui Zhong, Berislav V. Zlokovic

Research output: Contribution to journalArticlepeer-review

368 Scopus citations


Low-density lipoprotein receptor-related protein-1 (LRP) on brain capillaries clears amyloid β-peptide (Aβ) from brain. Here, we show that soluble circulating LRP (sLRP) provides key endogenous peripheral 'sink' activity for Aβ in humans. Recombinant LRP cluster IV (LRP-IV) bound Aβ in plasma in mice and Alzheimer's disease-affected humans with compromised sLRP-mediated Aβ binding, and reduced Aβ-related pathology and dysfunction in a mouse model of Alzheimer disease, suggesting that LRP-IV can effectively replace native sLRP and clear Aβ.

Original languageEnglish (US)
Pages (from-to)1029-1031
Number of pages3
JournalNature Medicine
Issue number9
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Clearance of amyloid-β by circulating lipoprotein receptors'. Together they form a unique fingerprint.

Cite this